Jason Chen

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

Sven J. van der Lee, Olivia J. Conway, Iris E. Jansen et al. · Acta Neuropathologica · 2019 · 131 citations · Full text

Medicine, Genetics, Molecular Genetics +13

A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibition

Joshua D. Bernstock, Nunzio Vicario, Rong Li et al. · OncoImmunology · 2019 · 33 citations · Full text

Medicine, Immunology, Oncology +17

A Nonsynonymous Mutation in PLCG2 Reduces the Risk of Alzheimer's Disease, Dementia with Lewy-Bodies and Frontotemporal Dementia, and Increases the Likelihood of Longevity

Sven J. van der Lee, Olivia J. Conway, Iris E. Jansen et al. · SSRN Electronic Journal · 2018 · 26 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Abstract 3509: The glutaminase inhibitor CB-839 synergizes with CDK4/6 and PARP inhibitors in pre-clinical tumor models

Ethan Emberley, Mark K. Bennett, Jason Chen et al. · Cancer Research · 2018 · 14 citations

Medicine, Oncology, Pharmacology +16